Twilight MasqueradeTwilight Masquerade🃏All Spinarak cards
Ask about Spinarak
Spinarak #4 Pokémon card from Twilight Masquerade

Spinarak 4/167

Twilight Masquerade

Find this card on eBay

Affiliate link · we may earn commission

Spinarak #4 from Twilight Masquerade currently trades at $0.13 raw, with PSA 10 copies reaching $30.56 — a 235.1x grade premium.
Current Prices (USD)
Ungraded
$0.13
PSA 7
$10.23
PSA 8
$10.23
PSA 9
$10.23
PSA 10
$30.56
ACE 10
BGS 10 Black
$200.00
CGC 10 Pristine
$32.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Spinarak 4/167 from Twilight Masquerade has a current raw market value of $0.13.

Current raw value
$0.13
PSA 9 value
$10.23
PSA 10 value
$30.56
View all cards from Twilight Masquerade
Collector Intel
235.1x
Raw → PSA 10
High-risk grade
78.7x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 235x the raw price. The expected value accounts for the realistic probability.
$0
Buy Raw
~$25
Grading Fee
PSA Standard
$31
PSA 10 Value
+$5
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$1078.7x raw
PSA 10$31235.1x raw

Frequently asked questions

How much is Spinarak #4 from Twilight Masquerade worth?+
Spinarak #4 from Twilight Masquerade is currently worth Raw: $0.13, PSA 9: $10.23, PSA 10: $30.56 based on recent sold listings. Prices update daily from real eBay sales.
Is Spinarak #4 worth grading?+
The PSA 10 price of $30.56 is 235.1× the raw price of $0.13. After a ~$25 grading fee, a PSA 10 result would net approximately $30.43 — assuming the card grades a 10.
Where do PokePrices Spinarak #4 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.